| 注册
首页|期刊导航|中国当代医药|氯雷他定分散片口服联合布地奈德压缩雾化吸入治疗妊娠期支气管炎的临床研究

氯雷他定分散片口服联合布地奈德压缩雾化吸入治疗妊娠期支气管炎的临床研究

蔡雪清 黄翌 冯妞妞

中国当代医药2016,Vol.23Issue(19):19-22,4.
中国当代医药2016,Vol.23Issue(19):19-22,4.

氯雷他定分散片口服联合布地奈德压缩雾化吸入治疗妊娠期支气管炎的临床研究

Clinical research on combination of application of oral loratadine dis-persible tablets and budesonide aerosol inhalation in treatment of preg-nancy bronchitis

蔡雪清 1黄翌 1冯妞妞1

作者信息

  • 1. 广州市花都区妇幼保健院内科,广州 510800
  • 折叠

摘要

Abstract

Objective To make a study on the clinical effectiveness of combination of application of oral loratadine dis-persible tablets and budesonide aerosol inhalation in the treatment of pregnancy bronchitis.Methods Altogether 83 cas-es of pregnant women with bronchitis who had been treated in our hospital from March 2014 to November 2015 were selected as the object and randomly divided into two groups:single drug group and combination group.Patients in single drug group were administered with oral loratadine dispersible tablets;combination group accepted budesonide aerosol inhalation on the basis of single drug group.Then,multiple indicators were observed and compared between two groups, including the effect rate of treatment of pregnancy bronchitis;the difference of pre- and post-treatment tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6),C-reactive protein (CRP) and quality of life;the incidence of adverse reactions;fever clearance time,the disappearance time of cough,wheezing and pulmonary rales.Results The curative effectiveness of combination group was higher than that in single drug group with statistical difference (P﹤0.05).The post-treatment TNF-α,IL-6,CRP and quality of life of combination group was highly improved than that of single drug group respec-tively,with statistical difference (P﹤0.05).The incidence of adverse reactions in two groups compared with no statistical differenc (P﹥0.05).Combination group took short er defervescence time and disappearance time of cough,wheezing and pulmonary rales than single drug group with statistical difference (P﹤0.05).Conclusion Combination of application of o-ral loratadine dispersible tablets and budesonide aerosol inhalation has demonstrated its clinical curative effectiveness and high safety in the treatment of pregnancy bronchitis,which can effectively improve patients' clinical symptoms and inflammatory level,promote the subsidence of clinical symptoms and the quality of life,and it deserves clinical popular-ization.

关键词

氯雷他定分散片/布地奈德/压缩雾化吸入/妊娠期支气管炎

Key words

Loratadine dispersible tablets/Budesonide/Aerosol inhalation/Pregnancy bronchitis

分类

医药卫生

引用本文复制引用

蔡雪清,黄翌,冯妞妞..氯雷他定分散片口服联合布地奈德压缩雾化吸入治疗妊娠期支气管炎的临床研究[J].中国当代医药,2016,23(19):19-22,4.

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文